ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2331

Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis

Jasvinder A. Singh1, Bradley Young2, Shawna Watson3, jorge perez2, Gerald McGwin2 and Brent Ponce2, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3university of Alabama at Birmingham, Birmingham, AL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthroplasty, rheumatoid arthritis (RA) and utilization review

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Orthopedics, Low Back Pain and Rehabilitation - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The purpose of this study was to analyze time-trends in various types of total joint arthroplasty (TJA) and assess if the proportion of the procedures performed on patients with RA has changed over time.

Methods: The Nationwide Inpatient Sample (NIS) database was queried from 2002 to 2012 to identify the number of patients per year undergoing TJA of the shoulder (TSA), elbow (TEA), knee (TKA), hip (THA), and ankle (TAA). We determined the proportion of these patients with a diagnosis of RA. Consistent with the design of the NIS, sampling weights were applied to obtain national estimates. Population-based rates of TJA were calculated using population estimates from the U.S. Census Bureau.

Results: During the study period, the overall utilization of TJA increased by 64.7% while the prevalence of comorbid RA in all TJA increased 0.1%. However, when stratified by specific joint, the prevalence of RA in patients undergoing TJA significantly decreased (p < 0.05) by 12% for TEA and 0.9% for TSA, decreased 4.6% (p = 0.06) for TAA, while there were increases of 0.2% for THA and 0.1% for TKA.

Conclusion: While the incidence of TJA is increasing nationally, the epidemiological landscape of TSA, TEA, and TAA performed in the RA population has varied. Such findings may be evidence of the successful early implementation of biological DMARD therapy and/or adoption of aggressive treatment strategies using combinations of traditional and biological DMARDs.


Disclosure: J. A. Singh, TAP, Savient, 2,Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Crealta and Allergan pharmaceuticals, WebMD, UBM LLC and the American College of Rheumatology, 5; B. Young, None; S. Watson, None; J. perez, None; G. McGwin, None; B. Ponce, None.

To cite this abstract in AMA style:

Singh JA, Young B, Watson S, perez J, McGwin G, Ponce B. Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/trends-in-joint-replacement-surgery-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-in-joint-replacement-surgery-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology